Form 4: PAVM: Insider Granted Restricted Stock

PAVM Inc. reports that President and CFO Dennis M. McGrath was granted 180,000 shares of restricted stock under the company's Long-Term Incentive Equity Plan.

Summary

• Dennis M. McGrath, President and CFO of PAVmed Inc. (PAVM), received a grant of 180,000 shares of common stock.
• This grant is part of the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan.
• The restricted stock has a single vesting date of May 20, 2029, and is subject to forfeiture if the service period is not completed.
• The transaction date was April 2, 2026, with a reported acquisition value of $0.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard executive stock grant which is typical for executive compensation and retention, without immediate financial implications or significant strategic shifts.

Positives

• Grant of restricted stock to a key executive (President and CFO) indicates a commitment to retaining and incentivizing leadership.
• The grant is part of a long-term incentive plan, suggesting a focus on sustained performance and company growth.

Negatives

• The restricted stock is subject to forfeiture, meaning the executive may not ultimately receive the full benefit if service conditions are not met.
• The grant has a long vesting period (until May 20, 2029), which could be seen as a long-term commitment rather than immediate reward.

Risks

• The restricted stock is subject to forfeiture if the requisite service period is not completed, posing a risk to the executive's ultimate benefit.
• The long vesting period until May 20, 2029, means the executive's continued employment with the company is a condition for receiving the shares.

Future Outlook

The filing itself does not contain forward-looking statements or guidance. It is a report of a stock grant to an executive.

Industry Context

StockSavvy.ai notes that grants of restricted stock to senior executives are a common practice in the biotechnology and healthcare sectors, including companies like PAVmed Inc., to align executive interests with long-term shareholder value and to aid in talent retention.

Stakeholder Impact

• Shareholders: The grant is a form of compensation and incentive for a key executive, intended to align their interests with long-term company performance and value creation.
• Employees: May signal the company's commitment to its executive team and its long-term incentive structures.
• Management: Reinforces the executive's role and commitment to the company through a long-term equity award.

Next Steps

• Dennis M. McGrath must complete the requisite service period to avoid forfeiture of the restricted stock.
• The restricted stock will vest on May 20, 2029.

Key Dates

Keywords

PAVM, PAVmed Inc., Form 4, Insider Trading, Restricted Stock, Equity Incentive Plan, Dennis M. McGrath, Executive Compensation, Vesting Schedule